PMC:7299399 / 30635-31016 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T135","span":{"begin":137,"end":145},"obj":"Body_part"},{"id":"T136","span":{"begin":256,"end":261},"obj":"Body_part"},{"id":"T137","span":{"begin":335,"end":342},"obj":"Body_part"}],"attributes":[{"id":"A135","pred":"fma_id","subj":"T135","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A136","pred":"fma_id","subj":"T136","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A137","pred":"fma_id","subj":"T137","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"Nanomaterials have been exploited to adjust the immune response to an optimized level, and such proprieties might be explored to inhibit cytokine releases.99 Nanosystems can enhance the specificity/efficiency of immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T31","span":{"begin":347,"end":353},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"uberon_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"Nanomaterials have been exploited to adjust the immune response to an optimized level, and such proprieties might be explored to inhibit cytokine releases.99 Nanosystems can enhance the specificity/efficiency of immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T282","span":{"begin":256,"end":261},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T283","span":{"begin":347,"end":353},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"Nanomaterials have been exploited to adjust the immune response to an optimized level, and such proprieties might be explored to inhibit cytokine releases.99 Nanosystems can enhance the specificity/efficiency of immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T228","span":{"begin":212,"end":229},"obj":"Chemical"},{"id":"T229","span":{"begin":293,"end":297},"obj":"Chemical"},{"id":"T230","span":{"begin":304,"end":308},"obj":"Chemical"}],"attributes":[{"id":"A228","pred":"chebi_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/CHEBI_35705"},{"id":"A229","pred":"chebi_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A230","pred":"chebi_id","subj":"T230","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Nanomaterials have been exploited to adjust the immune response to an optimized level, and such proprieties might be explored to inhibit cytokine releases.99 Nanosystems can enhance the specificity/efficiency of immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T40","span":{"begin":48,"end":63},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"Nanomaterials have been exploited to adjust the immune response to an optimized level, and such proprieties might be explored to inhibit cytokine releases.99 Nanosystems can enhance the specificity/efficiency of immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}

{"project":"LitCovid-sentences","denotations":[{"id":"T120","span":{"begin":0,"end":381},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Nanomaterials have been exploited to adjust the immune response to an optimized level, and such proprieties might be explored to inhibit cytokine releases.99 Nanosystems can enhance the specificity/efficiency of immunosuppressant delivery to target immune cells, with consequent reductions in drug dose, drug distribution to nontarget tissues and organs, and possible side effects."}